Skip to search formSkip to main contentSkip to account menu

Cormelian-Digotab

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

dilazep, beta-acetyldigoxin drug combination

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1976
1976
[Therapy of coronary heart disease using Cormelian-Digotab: influence of the duration of therapy. 2. Field study by 107 physicians].
1976
1976
[Studies on the bioavailability of the individual components from a combination of dilazep and beta-acetyldigoxin (author's transl)].
Original tablets of Cormelian [= 50 mg 1,4-bis[3-(3,4,5-trimethoxybenzoyl-oxy)-propyl]-perhydro-1,4-diazepine (dilazep)] and… 
1975
1975
[Therapy of coronary heart disease using Cormelian-Digotab. First communication on a field experiment of 107 residential physicians].
1974
1974
[Report on the clinical testing of Cormelian-Digotab].
1974
1974
[Therapy of coronary heart disease using Cormelian-Digotab. Results of a double blind study].
1974
1974
[Treatment of therapy-resistant stenocardias associated with myocardial insufficiency using cormelian-digotab in a rehabilitation clinic].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)